{
    "nct_id": "NCT02916745",
    "official_title": "Multicenter, Prospective, OL, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung",
    "inclusion_criteria": "* Male or female aged 18 or older\n* Diagnosed with histologically confirmed solid tumor located in the peripheral lung\n* Not candidate for curative surgery, is unfit for surgery, or does not wish to undergo curative surgery\n* May be candidate for, have failed, or does not wish to undergo radiation therapy\n* The tumor is ≤ 3 cm in size and clearly observable in computerized tomography (CT scan)\n* Able to sign an informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Diagnostic of small cell lung cancer\n* Solid tumor located in central lung\n* Presence of concurrent non-solid malignancy\n* Abnormal blood results\n* Received chemotherapy/immunotherapy in the last 4 weeks\n* Tumor invades a major blood vessel\n* Porphyria or known hypersensitivity to Photofrin® or porphyrin-like compounds or to any of its excipients\n* Planned surgical procedure within the next 90 days\n* Coexisting ophthalmic disease likely to require slit-lamp examination within the next 90 days\n* Acute or chronic medical or psychological illnesses that prevent endoscopy procedures\n* Pregnant or intend to become pregnant, breastfeeding or intend to breastfeed during the study\n* Received PDT during the past 3 months\n* Severe impairment of your kidney or liver function\n* Participates or intends to participate in another drug study (other than observational studies) during the study",
    "miscellaneous_criteria": ""
}